Literature DB >> 19710497

Renal sympathetic-nerve ablation for uncontrolled hypertension.

Markus P Schlaich, Paul A Sobotka, Henry Krum, Elisabeth Lambert, Murray D Esler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19710497     DOI： 10.1056/NEJMc0904179

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  203 in total

1.  Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience.

Authors:  G Simonetti; A Spinelli; R Gandini; V Da Ros; E Gaspari; I Coco; M De Francesco; D Santucci; N Di Daniele; R Lauro
Journal:  Radiol Med       Date:  2012-01-07       Impact factor: 3.469

Review 2.  Origins of Western diseases.

Authors:  Mj Quinn
Journal:  J R Soc Med       Date:  2011-11       Impact factor: 5.344

Review 3.  A sympathetic view of human obesity.

Authors:  Elisabeth A Lambert; Nora E Straznicky; Gavin W Lambert
Journal:  Clin Auton Res       Date:  2012-06-21       Impact factor: 4.435

Review 4.  Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension.

Authors:  Markus P Schlaich; Henry Krum; Paul A Sobotka
Journal:  Curr Hypertens Rep       Date:  2010-02       Impact factor: 5.369

Review 5.  New therapeutic approaches to resistant hypertension.

Authors:  Markus P Schlaich; Henry Krum; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2010-08       Impact factor: 5.369

Review 6.  Novel therapeutic targets for hypertension.

Authors:  Ludovit Paulis; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 7.  Premise, promise, and potential limitations of invasive devices to treat hypertension.

Authors:  Elizabeth A Martin; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

Review 8.  The rise, fall, and possible resurrection of renal denervation.

Authors:  Rajiv Gulati; Claire E Raphael; Manuela Negoita; Stuart J Pocock; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

Review 9.  Device-based therapies for arterial hypertension.

Authors:  Lucas Lauder; Michel Azizi; Ajay J Kirtane; Michael Böhm; Felix Mahfoud
Journal:  Nat Rev Cardiol       Date:  2020-04-14       Impact factor: 32.419

Review 10.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.